Skip to main content
Figure 4 | BMC Research Notes

Figure 4

From: No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer

Figure 4

RASSF1A and MAL MS-HRM of breast carcinoma samples. A. RASSF1A MS-HRM demonstrates generally homogeneous methylation in the breast carcinoma samples at different percentages of methylation ranging from 10 to 50% methylation. B. Both homogeneous (the sharp peak seen for sample 5) and heterogeneous methylation (the more complex melting profiles across both unmethylated and methylated peaks seen in the other samples) can be observed for MAL.

Back to article page